Ignite Creation Date:
2024-05-06 @ 5:48 PM
Last Modification Date:
2024-10-26 @ 2:35 PM
Study NCT ID:
NCT05433480
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-07-27
First Post:
2022-06-16
Brief Title:
A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR and HER2- Locally Advanced Recurrent or Metastatic Breast Cancer
Sponsor:
Betta Pharmaceuticals Co Ltd
Organization:
Betta Pharmaceuticals Co Ltd
Organization Data
Organization:
Betta Pharmaceuticals Co Ltd
Class:
INDUSTRY
Study ID:
BTP-66732
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Betta Pharmaceuticals Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None